Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis
CCT196969 can inhibit TNBC by down-regulating expression of ASNS.
»
08/08/25
From standardized to individualized margins for online adaptive tumor dose escalation in rectal cancer
Distance to anorectal junction significantly influenced magnitude and direction of intrafraction motion.
»
08/08/25
Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancer
eHsp70 values significantly higher in patients with NSCLC.
»
08/09/25
Predicting survival of persons with newly-diagnosed multiple myeloma
Merged nomogram increased 5-year survival AUCs.
»
08/09/25
Promoting mitochondrial fusion is protective against cancer-induced muscle detriments in males and females
Promoting mitochondrial fusion via OPA1 induction improved cachectic outcomes.
»
08/11/25
Preoperative risk stratification in endometrial cancer using ESGO/ESTRO/ESP 2021 guidelines: accuracy with and without molecular classification
Preoperative assessment without molecular input underestimated risk stratification.
»
08/11/25
Adverse drug events of immune checkpoint inhibitors - a retrospective, descriptive real-world data analysis
Nearly half of patients experienced ≥ 1 irAEs.
»
08/11/25
High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy
High tumour ribosomal RNA degradation during neoadjuvant chemotherapy associated with improved DFS.
»
08/11/25
Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis
HER2-null subset showed preference for SG-first.
»
08/11/25
Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Non-catalytic function of SETD1A in breast cancer cells depends on its cyclin K-associated FLOS domain.
»
08/11/25
< Prev
Next >